2013Linchuang huicuiRequires access

Influence of atorvastatin on serum tumor necrosis factor-α and interleukin-6 in patients of acute ischemic stroke with normal lipidemia

MA Jin-liang

Open publisher page 0 citations

Abstract

Objective To observe the influence of atorvastatin on serum tumor necrosis factor-α(TNF-α) and interleukin-6(IL-6) in patients of acute ischemic stroke with normal lipidemia.Methods Sixty-two cases of patients of acute ischemic stroke with normal lipidemia were randomly divided into the treatment group(n=31) and the control group(n=31).The patients of control group were treated with routine therapy only,whereas the patients of treatment group were treated with atorvastatin 20 mg once daily based on routine therapy for 12 weeks.Serum total cholesterol(TC),triglyceride(TG),lower density lipid-cholesterol(LDL-C),high density lipid-cholesterol(HDL-C),TNF-α and IL-6 levels were measured and National Institutes of Health Stroke Scale(NIHSS) was evaluated before and after treatment.Results After treatment,the serum levels of TC,TG,LDL-C,TNF-α and IL-6,NIHSS in treatment group were significantly lower than those in control group,TC(4.21±0.88) mmol/L vs(4.69±0.93) mmol/L,TG(1.12±0.46) mmol/L vs(1.26±0.42) mmol/L,LDL-C(2.23±0.55) mmol/L vs(2.82±0.59) mmol/L,NIHSS(10.56±3.61) marks vs(15.35±3.92) marks,TNF-α(9.95±3.68) μg/L vs(15.42±3.79) μg/L,IL-6(10.34±2.81) μg/L vs(14.27±3.12) μg/L.However,the serum level of HDL-C in treatment group was significantly higher than that in control group,(1.29±0.38)mmol/L vs(1.11±0.34) mmol/L(P0.05).Conclusion Atorvastatin proves significant effect in neurological function improvement of patients with acute ischemic stroke in normal lipidemia.Its mechanism may be related with reducing the production of TNF-α and IL-6 and inhibiting inflammatory reaction.

About this research paper

What this paper is about

Objective To observe the influence of atorvastatin on serum tumor necrosis factor-α(TNF-α) and interleukin-6(IL-6) in patients of acute ischemic stroke with normal lipidemia.Methods Sixty-two cases of patients of acute ischemic stroke with normal lipidemia were randomly divided into the treatment group(n=31) and the control group(n=31).The patients of control group were treated with routine therapy only,whereas the patients of treatment group were treated with atorvastatin 20 mg once daily based on routine therapy for 12 weeks.Serum total cholesterol(TC),triglyceride(TG),lower density lipid-cholesterol(LDL-C),high density lipid-cholesterol(HDL-C),TNF-α and IL-6 levels were measured and National Institutes of Health Stroke Scale(NIHSS) was evaluated before and after treatment.Results After treatment,the serum levels of TC,TG,LDL-C,TNF-α and IL-6,NIHSS in treatment group were significantly lower than those in control group,TC(4.21±0.88) mmol/L vs(4.69±0.93) mmol/L,TG(1.12±0.46) mmol/L vs(1.26±0.42) mmol/L,LDL-C(2.23±0.55) mmol/L vs(2.82±0.59) mmol/L,NIHSS(10.56±3.61) marks vs(15.35±3.92) marks,TNF-α(9.95±3.68) μg/L vs(15.42±3.79) μg/L,IL-6(10.34±2.81) μg/L vs(14.27±3.12) μg/L.However,the serum level of HDL-C in treatment group was significantly higher than that in control group,(1.29±0.38)mmol/L vs(1.11±0.34) mmol/L(P0.05).Conclusion Atorvastatin proves significant effect in neurological function improvement of patients with acute ischemic stroke in normal lipidemia.Its mechanism may be related with reducing the production of TNF-α and IL-6 and inhibiting inflammatory reaction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the influence of atorvastatin on serum tumor necrosis factor-α(TNF-α) and interleukin-6(IL-6) in patients of acute ischemic stroke with normal lipidemia.Methods Sixty-two cases of patients of acute ischemic stroke with normal lipidemia were randomly divided into the treatment group(n=31) and the control group(n=31).The patients of control group were treated with routine therapy only,whereas the patients of treatment group were treated with atorvastatin 20 mg once daily based on routine therapy for 12 weeks.Serum total cholesterol(TC),triglyceride(TG),lower density lipid-cholesterol(LDL-C),high density lipid-cholesterol(HDL-C),TNF-α and IL-6 levels were measured and National Institutes of Health Stroke Scale(NIHSS) was evaluated before and after treatment.Results After treatment,the serum levels of TC,TG,LDL-C,TNF-α and IL-6,NIHSS in treatment group were significantly lower than those in control group,TC(4.21±0.88) mmol/L vs(4.69±0.93) mmol/L,TG(1.12±0.46) mmol/L vs(1.26±0.42) mmol/L,LDL-C(2.23±0.55) mmol/L vs(2.82±0.59) mmol/L,NIHSS(10.56±3.61) marks vs(15.35±3.92) marks,TNF-α(9.95±3.68) μg/L vs(15.42±3.79) μg/L,IL-6(10.34±2.81) μg/L vs(14.27±3.12) μg/L.However,the serum level of HDL-C in treatment group was significantly higher than that in control group,(1.29±0.38)mmol/L vs(1.11±0.34) mmol/L(P0.05).Conclusion Atorvastatin proves significant effect in neurological function improvement of patients with acute ischemic stroke in normal lipidemia.Its mechanism may be related with reducing the production of TNF-α and IL-6 and inhibiting inflammatory reaction.

Key concepts: Medicine, Internal medicine, Atorvastatin, Triglyceride, Gastroenterology, Tumor necrosis factor alpha, Endocrinology, Cholesterol

Related papers

Back to paper searchBrowse research topicsOriginal source
Influence of atorvastatin on serum tumor necrosis factor-α and interleukin-6 in patients of acute ischemic stroke with normal lipidemia — Research Paper | ScholarLens